Research / FSI / Fundamental state Inspectable configuration
State dimensions Filing 0001493152-20-021300 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
43.93% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.capex_revenue_ratio
3.27% · OPTIONAL · NOT_ENOUGH_HISTORY
Operating cash generation RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
28.45% · OPTIONAL · NOT_ENOUGH_HISTORY
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
9.58% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
85.57% · OPTIONAL · NOT_ENOUGH_HISTORY
Gross margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.gross_margin
31.00% · CORE · NOT_ENOUGH_HISTORY
Operating margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.operating_margin
14.39% · CORE · NOT_ENOUGH_HISTORY
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
0.21% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.37% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 34 states Self-history eligible
Dec 31, 2021 9/9 normalized Amended as filed Mar 31, 2022 9/9 normalized Level 3 Jun 30, 2022 9/9 normalized Level 3 Sep 30, 2022 9/9 normalized Level 3 Dec 31, 2022 9/9 normalized Level 3 Mar 31, 2023 9/9 normalized Level 3 Jun 30, 2023 9/9 normalized Level 3 Sep 30, 2023 9/9 normalized Level 3 Dec 31, 2023 9/9 normalized Level 3 Mar 31, 2024 9/9 normalized Level 3 Dec 31, 2023 9/9 normalized Amended as filed Jun 30, 2024 9/9 normalized Level 3 Sep 30, 2024 9/9 normalized Level 3 Dec 31, 2024 9/9 normalized Level 3 Mar 31, 2025 9/9 normalized Level 3 Jun 30, 2025 9/9 normalized Level 3 Sep 30, 2025 9/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 54.39%
Current 43.93%
Delta -10.45% Capex Intensity Decreased
Previous 6.03%
Current 3.27%
Delta -2.76% Cash Generation Decreased
Previous 54.46%
Current 28.45%
Delta -26.01% Growth Decreased
Previous 13.87%
Current 9.58%
Delta -4.29% Inventory Pressure Decreased
Previous 102.41%
Current 85.57%
Delta -16.84% Margin Decreased
Previous 31.40%
Current 31.00%
Delta -0.40% Profitability Decreased
Previous 15.21%
Current 14.39%
Delta -0.82% R And D Intensity Increased
Previous 0.15%
Current 0.21%
Delta 0.06% Sbc Intensity Decreased
Previous 0.38%
Current 0.37%
Delta -0.01% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.